Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials.

Covariate imbalances may be producing false positives in subgroup analyses. mCART could be a useful tool to help prevent the false discovery of HTE subgroups in secondary analyses of randomized trial data.